STTK
USDShattuck Labs Inc. Common Stock
即時價格
價格圖表
關鍵指標
市場指標
開盤
$1.960
最高
$2.075
最低
$1.858
交易量
0.10M
公司基本面
市值
92.5M
行業
生物科技
國家
United States
交易統計
平均交易量
0.81M
交易所
NMS
貨幣
USD
52週範圍
相關新聞
Wedbush Initiates Coverage On Shattuck Labs with Outperform Rating, Announces Price Target of $4
Wedbush analyst David Nierengarten initiates coverage on Shattuck Labs with a Outperform rating and announces Price Target of $4.
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
— Aggregate net proceeds from private placement expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune disease — — Pro forma
Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease
– SL-325 is a potentially first-in-class DR3 antagonist antibody being developed for the treatment of Inflammatory Bowel Disease (IBD) and other inflammatory and immune-mediated diseases – – The Company is on track to
相關股票
DIN
Dine Brands Global Inc.
CRSP
CRISPR Therapeutics AG Common Shares
FLDDU
FTAC Emerald Acquisition Corp. Unit
DHF
BNY Mellon High Yield Strategies Fund
DCOMP
Dime Community Bancshares Inc. Fixed-Rate Non-Cumulative Perpetual Preferred Stock Series A
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。